The hyperparathyroidism market represents one of the most dynamic segments within endocrinology, characterized by rapid therapeutic advancement and evolving patient care paradigms. This complex endocrine disorder, affecting calcium homeostasis through excessive parathyroid hormone production, has prompted significant investment in novel treatment approaches and diagnostic...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Ελληνικά
Tiếng Việt